Select this product for Molecular Innovations name, N-Terminal Cys mutant (active wild type) and product number, NTCYSPAI-A. Human PAI-1 Recombinant Active N Terminal Mutation from Innovative Research has been recombinantly produced in E. coli and purified by affinity chromatography. This is a Frozen liquid buffered in 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; 1mM DTT; pH 6.6 and a purity of >95% as determined by SDS-PAGE. More Details: Species: Human Target: PAI-1 Purification Method: Affinity purified Purity: >95% as determined by SDS-PAGE Analysis Source: E. coli Storage Conditions: -70C Additional Information: Wild type PAI-1, cloned, with a cysteine residue at the N-terminus. Greater than 95% pure and 95% active. The protein is supplied in buffer with 1 mM DTT to prevent dimerization. This product can be used as a control in applications like ELISA and Western Blot. It can be used for a wide range of in vitro applications, including fibrinolysis, hypertension studies, inhibition, plasminogen activation, protein-protein interactions, receptor binding, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.

View all citations and product references

This material is sold for in-vitro use only for manufacturing and research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herin are offered for informational purposes only to be used solely for your consideration, investigation, and verification.

Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.

No Data Sheets available